Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Research Report 2023

The global Female Hypoactive Sexual Desire Disorder Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Female Hypoactive Sexual Desire Disorder Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Female Hypoactive Sexual Desire Disorder Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Female Hypoactive Sexual Desire Disorder Therapeutics in Out-Patient is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Female Hypoactive Sexual Desire Disorder Therapeutics include Emotional Brain BV, GlaxoSmithKline Plc, Palatin Technologies Inc, Pivot Pharmaceuticals Inc and Strategic Science & Technologies LLC, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Female Hypoactive Sexual Desire Disorder Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Hypoactive Sexual Desire Disorder Therapeutics.

The Female Hypoactive Sexual Desire Disorder Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Female Hypoactive Sexual Desire Disorder Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Female Hypoactive Sexual Desire Disorder Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 BP-101

1.2.3 Bremelanotide

1.2.4 Gepirone Hydrochloride ER

1.2.5 PVT-011

1.2.6 Others

1.3 Market by Application

1.3.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Out-Patient

1.3.3 In-Patient

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Perspective (2018-2029)

2.2 Female Hypoactive Sexual Desire Disorder Therapeutics Growth Trends by Region

2.2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Female Hypoactive Sexual Desire Disorder Therapeutics Market Dynamics

2.3.1 Female Hypoactive Sexual Desire Disorder Therapeutics Industry Trends

2.3.2 Female Hypoactive Sexual Desire Disorder Therapeutics Market Drivers

2.3.3 Female Hypoactive Sexual Desire Disorder Therapeutics Market Challenges

2.3.4 Female Hypoactive Sexual Desire Disorder Therapeutics Market Restraints

3.1 Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Revenue

3.1.1 Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue

3.4 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Concentration Ratio

3.4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in 2022

3.5 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players Head office and Area Served

3.6 Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Product Solution and Service

3.7 Date of Enter into Female Hypoactive Sexual Desire Disorder Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2018-2029)

6.2 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2018-2023)

6.4 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2018-2029)

7.2 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2018-2023)

7.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2018-2029)

9.2 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Emotional Brain BV

11.1.1 Emotional Brain BV Company Detail

11.1.2 Emotional Brain BV Business Overview

11.1.3 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Introduction

11.1.4 Emotional Brain BV Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023)

11.1.5 Emotional Brain BV Recent Development

11.2 GlaxoSmithKline Plc

11.2.1 GlaxoSmithKline Plc Company Detail

11.2.2 GlaxoSmithKline Plc Business Overview

11.2.3 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction

11.2.4 GlaxoSmithKline Plc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023)

11.2.5 GlaxoSmithKline Plc Recent Development

11.3 Palatin Technologies Inc

11.3.1 Palatin Technologies Inc Company Detail

11.3.2 Palatin Technologies Inc Business Overview

11.3.3 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction

11.3.4 Palatin Technologies Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023)

11.3.5 Palatin Technologies Inc Recent Development

11.4 Pivot Pharmaceuticals Inc

11.4.1 Pivot Pharmaceuticals Inc Company Detail

11.4.2 Pivot Pharmaceuticals Inc Business Overview

11.4.3 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction

11.4.4 Pivot Pharmaceuticals Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023)

11.4.5 Pivot Pharmaceuticals Inc Recent Development

11.5 Strategic Science & Technologies LLC

11.5.1 Strategic Science & Technologies LLC Company Detail

11.5.2 Strategic Science & Technologies LLC Business Overview

11.5.3 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Introduction

11.5.4 Strategic Science & Technologies LLC Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023)

11.5.5 Strategic Science & Technologies LLC Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of BP-101

    Table 3. Key Players of Bremelanotide

    Table 4. Key Players of Gepirone Hydrochloride ER

    Table 5. Key Players of PVT-011

    Table 6. Key Players of Others

    Table 7. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Region (2018-2023)

    Table 11. Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Region (2024-2029)

    Table 13. Female Hypoactive Sexual Desire Disorder Therapeutics Market Trends

    Table 14. Female Hypoactive Sexual Desire Disorder Therapeutics Market Drivers

    Table 15. Female Hypoactive Sexual Desire Disorder Therapeutics Market Challenges

    Table 16. Female Hypoactive Sexual Desire Disorder Therapeutics Market Restraints

    Table 17. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Players (2018-2023)

    Table 19. Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics as of 2022)

    Table 20. Ranking of Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Product Solution and Service

    Table 24. Date of Enter into Female Hypoactive Sexual Desire Disorder Therapeutics Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type (2018-2023)

    Table 28. Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type (2024-2029)

    Table 30. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Application (2018-2023)

    Table 32. Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Application (2024-2029)

    Table 34. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Emotional Brain BV Company Detail

    Table 50. Emotional Brain BV Business Overview

    Table 51. Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Product

    Table 52. Emotional Brain BV Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023) & (US$ Million)

    Table 53. Emotional Brain BV Recent Development

    Table 54. GlaxoSmithKline Plc Company Detail

    Table 55. GlaxoSmithKline Plc Business Overview

    Table 56. GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Product

    Table 57. GlaxoSmithKline Plc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023) & (US$ Million)

    Table 58. GlaxoSmithKline Plc Recent Development

    Table 59. Palatin Technologies Inc Company Detail

    Table 60. Palatin Technologies Inc Business Overview

    Table 61. Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product

    Table 62. Palatin Technologies Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023) & (US$ Million)

    Table 63. Palatin Technologies Inc Recent Development

    Table 64. Pivot Pharmaceuticals Inc Company Detail

    Table 65. Pivot Pharmaceuticals Inc Business Overview

    Table 66. Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product

    Table 67. Pivot Pharmaceuticals Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023) & (US$ Million)

    Table 68. Pivot Pharmaceuticals Inc Recent Development

    Table 69. Strategic Science & Technologies LLC Company Detail

    Table 70. Strategic Science & Technologies LLC Business Overview

    Table 71. Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Product

    Table 72. Strategic Science & Technologies LLC Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023) & (US$ Million)

    Table 73. Strategic Science & Technologies LLC Recent Development

    Table 74. Research Programs/Design for This Report

    Table 75. Key Data Information from Secondary Sources

    Table 76. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. BP-101 Features

    Figure 4. Bremelanotide Features

    Figure 5. Gepirone Hydrochloride ER Features

    Figure 6. PVT-011 Features

    Figure 7. Others Features

    Figure 8. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application: 2022 VS 2029

    Figure 10. Out-Patient Case Studies

    Figure 11. In-Patient Case Studies

    Figure 12. Female Hypoactive Sexual Desire Disorder Therapeutics Report Years Considered

    Figure 13. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Region: 2022 VS 2029

    Figure 16. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Players in 2022

    Figure 17. Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in 2022

    Figure 19. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2018-2029)

    Figure 21. United States Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2018-2029)

    Figure 25. Germany Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Region (2018-2029)

    Figure 33. China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2018-2029)

    Figure 41. Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2018-2029)

    Figure 45. Turkey Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Emotional Brain BV Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023)

    Figure 48. GlaxoSmithKline Plc Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023)

    Figure 49. Palatin Technologies Inc Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023)

    Figure 50. Pivot Pharmaceuticals Inc Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023)

    Figure 51. Strategic Science & Technologies LLC Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2018-2023)

    Figure 52. Bottom-up and Top-down Approaches for This Report

    Figure 53. Data Triangulation

    Figure 54. Key Executives Interviewed